how to get insurance to approve glp 1 MCT2D Temps may rise, but your

* Based on the trial product estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies

Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification

That means burning 200-300 fewer calories dailyeven if youre eating the same

However, because its still relatively new, its long-term effectiveness isnt as extensively established compared to the injectable form